Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.
Open Access
- 1 September 1988
- Vol. 29 (9) , 1194-1197
- https://doi.org/10.1136/gut.29.9.1194
Abstract
A recently developed double test for detecting faecal occult blood (a sensitive guaiac test combined with a quantitative immunological human haemoglobin test), was adapted to population screening. The study involved an unselected population of 10,343, aged 49-74 years. There was 66.5% participation. 174 colonoscopies were done, yielding seven adenocarcinomas, 44 adenomas and four hyperplastic polyps. By eliminating benign anal tract bleeding, the number of endoscopies decreased from 340 to 174. Most tumours showed an absorbance over 0.80, and it is suggested that by setting the lower limit of positivity at the 0.80 absorbance level, the number of clinical examinations could fall to about 1%, without substantially missing tumours.This publication has 7 references indexed in Scilit:
- The St. Mark s Neoplastic Polyp Follow-Up Study1Published by S. Karger AG ,2015
- Participation in Mass Screening for Colorectal Cancer with Fecal Occult Blood TestScandinavian Journal of Gastroenterology, 1986
- A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancerBritish Journal of Cancer, 1985
- Occult blood screening for colorectal carcinoma: A critical reviewGastroenterology, 1985
- Five guaiac-based tests for occult blood in faeces compared in vitro and in vivoScandinavian Journal of Clinical and Laboratory Investigation, 1984
- Immunological detection of faecal occult blood in colorectal cancerBritish Journal of Cancer, 1984